BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38423847)

  • 1. Clonal hematopoiesis and autoimmunity.
    Kishtagari A; Corty RW; Visconte V
    Semin Hematol; 2024 Feb; 61(1):3-8. PubMed ID: 38423847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
    Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
    Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis.
    Polizio AH; Park E; Walsh K
    Curr Atheroscler Rep; 2023 Mar; 25(3):105-111. PubMed ID: 36808603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with clonal hematopoiesis and interaction with marrow environment.
    Nannya Y
    J Bone Miner Metab; 2023 May; 41(3):380-387. PubMed ID: 36346484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2 mutation as prototypic clonal hematopoiesis lesion.
    Guarnera L; Jha BK
    Semin Hematol; 2024 Feb; 61(1):51-60. PubMed ID: 38431463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
    Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
    J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis and bone marrow inflammation.
    Xie X; Su M; Ren K; Ma X; Lv Z; Li Z; Mei Y; Ji P
    Transl Res; 2023 May; 255():159-170. PubMed ID: 36347490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells.
    Kandarakov O; Belyavsky A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis and inflammation - the perpetual cycle.
    Avagyan S; Zon LI
    Trends Cell Biol; 2023 Aug; 33(8):695-707. PubMed ID: 36593155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes and consequences of clonal hematopoiesis.
    Weeks LD; Ebert BL
    Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age and number of mutations on the size of clonal hematopoiesis.
    Wang K; Zhang W; Yi L; Zhao M; Li PY; Fu MH; Lin R; Zhu YM; Li JF; Yang WP; Fang H; Chen Z; Cai WW; Ren RB
    Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2319364121. PubMed ID: 38359296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway.
    Fujino T; Goyama S; Sugiura Y; Inoue D; Asada S; Yamasaki S; Matsumoto A; Yamaguchi K; Isobe Y; Tsuchiya A; Shikata S; Sato N; Morinaga H; Fukuyama T; Tanaka Y; Fukushima T; Takeda R; Yamamoto K; Honda H; Nishimura EK; Furukawa Y; Shibata T; Abdel-Wahab O; Suematsu M; Kitamura T
    Nat Commun; 2021 Mar; 12(1):1826. PubMed ID: 33758188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in understanding the molecular basis of clonal hematopoiesis.
    Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
    Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal hematopoiesis, aging, and cardiovascular diseases.
    Pardali E; Dimmeler S; Zeiher AM; Rieger MA
    Exp Hematol; 2020 Mar; 83():95-104. PubMed ID: 31891750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
    Zhang Z; Sun J
    Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline predisposition to clonal hematopoiesis.
    Liu J; Osman AEG; Bolton K; Godley LA
    Leuk Res; 2023 Sep; 132():107344. PubMed ID: 37421681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.